Добавил:
Sekretar
kiopkiopkiop18@yandex.ru
t.me/Prokururor I Вовсе не секретарь, но почту проверяю
Опубликованный материал нарушает ваши авторские права? Сообщите нам.
Вуз:
Предмет:
Файл:Ординатура / Хирургия / Библиотека им академика М.И. Перельмана / Книга_239_библиотеки_им_акад_М_И_Перельмана
.pdf
161
Vol. 7, N 3. – P. 45–49.
82. Impact of intensive glycemic control on the incidence of atrial fibrillation and
associated cardiovascular outcomes in patients with type 2 diabetes mellitus (from the
action to control cardiovascular risk in diabetes study) / O. Fatemi, E. Yuriditsky,
C. Tsioufis [et al.] // The American journal of cardiology. – 2014. – Vol. 114, N 8. –
P. 1217–1222.
83. N-terminal pro-BNP in acute coronary syndrome patients with ST elevation
(STE-ACS) versus non ST elevation (NSTE-ACS) / R. Salama, A. El-Moniem,
T. Samor [et al.] // International journal of health sciences. – 2011. – Vol. 5, N 2.
– P. 136–145.
84. Relation of heart-rate recovery to new onset heart failure and atrial fibrillation
in patients with diabetes mellitus and preserved ejection fraction / K. Negishi,
S. Seicean, T. Negishi [et al.] // The American journal of cardiology. – 2013. – Vol. 111,
N 5. – P. 748–753.
85. Post-mortem pathologic and genetic studies in “dead in bed syndrome” cases
in type 1 diabetes mellitus / E. Tu, R.D. Bagnall, J. Duflou [et al.] // Human Pathology.
– 2010. – Vol. 41, N 3. – P. 392–400.
86. Diabetic dead-in-bed syndrome: a possible link to a cardiac ion channelopathy
/ J.R. Skinner, R. Marquis-Nicholson, A. Luangpraseuth [et al.] // Case reports in
medicine. – 2014. – Vol. 2014. – P. 1–5.
87. Familial Brugada syndrome uncovered by hyperkalaemic diabetic
ketoacidosis / P.G. Postema, A.P. Vlaar, H.L. Tan [et al.] // Europace. – 2011. – Vol. 13,
N 10. – P. 1509–1510.
88. Fagher, K. The impact of metabolic control and QTc prolongation on
all-cause mortality in patients with type 2 diabetes and foot ulcers / K. Fagher,
https://t.me/med1917
162
M. Löndahl. // Diabetologia. – 2013. – Vol. 56, N 5. – P. 1140–1147.
89. Assessment of atrial electromechanical delay, diastolic functions, and left
atrial mechanical functions in patients with type 1 diabetes mellitus / G. Acar, A. Akcay,
A. Sokmen [et al.] // Journal of the American society of echocardiography. – 2009. –
Vol. 22, N 6. – P. 732–738.
90. Морфология нарушений локальной сократимости миокарда в случаях
тяжелой левожелудочковой дисфункции / Ю.В. Роговская, Ю.М. Падеров, М.В.
Балахонова [и др.]. / Сибирский научный медицинский журнал. – 2011. – Т. 31, №
4. – С. 50–53.
91. Long-term recording of cardiac arrhythmias with an implantable cardiac
monitor in patients with reduced ejection fraction after acute myocardial infarction:the
cardiac arrhythmias and risk stratification after acute myocardial infarction (CARISMA)
study /P.E. Bloch-Thomsen, C. Jons, M.J. Raatikainen [et al.] // Circulation. – 2010. –
Vol. 122, N 13. – P. 1258–1264.
92. Influence of diabetes on characteristics and outcomes in patients hospitalized
with heart failure: a report from the organized program to initiate lifesaving treatment in
hospitalized patients with heart failure (OPTIMIZE-HF) / B.H. Greenberg,
W.T. Abraham, N.M. Albert [et al.] // American heart journal. – 2007. – Vol. 154, N 2.
– e1-8.
93. Temporal trends and factors associated with diabetes mellitus among patients
hospitalized with heart failure: findings from get with the guidelines-heart failure
registry / J.B. Echouffo-Tcheugui, H. Xu, A.D. DeVore [et al.] // American heart
journal. – 2016. – Vol. 182. – P. 9–20.
94. 2017 ACC/AHA/HFSA focused update of the 2013 ACCF/AHA guideline for
the management of heart failure: a report of the American college of
https://t.me/med1917
163
cardiology/American heart association task force on clinical practice guidelines and the
heart failure society of America / C.W. Yancy, M. Jessup, B. Bozkurt [et al.] // Journal
of cardiac failure. – 2017. – Vol. 23, N 8. – P. 628–651.
95. AGEs-RAGE system mediates atrial structural remodeling in the diabetic rat /
T. Kato, T. Yamashita, A. Sekiguchi [et al.] // Journal of cardiovascular
electrophysiology. – 2008. – Vol. 19, N 4. – P. 415–420.
96. Interrelationship between diabetes mellitus and heart failure: the role of
peroxisome proliferator-activated receptors in left ventricle performance /
E. Oikonomou, K. Mourouzis, P. Fountoulakis [et al.] // Heart failure reviews. – 2018.
– Vol. 23, N 3. – P. 389–408.
97. 2021 Update to the 2017 ACC expert consensus decision pathway for
optimization of heart failure treatment: answers to 10 pivotal issues about heart failure
with reduced ejection fraction: a report of the American college of cardiology solution
set oversight committee / T.M. Maddox, J.L. Januzzi Jr, L.A. Allen [et al.] // Journal of
the American college of cardiology. – 2021. – Vol. 77, N 6. – P. 772–810.
98. Recommendations for cardiac chamber quantification by echocardiography in
adults: an update from the American society of echocardiography and the European
association of cardiovascular imaging / R.M. Lang, L.P. Badano, V. Moravi [et al.] //
Journal of the American society of echocardiography. – 2015. – Vol. 28, N 1. – P. 1–39.
99. Клинические рекомендации ОССН-РКО-РНМОТ. Сердечная
недостаточность: хроническая (ХСН) и острая декомпенсированная (ОДСН).
Диагностика, профилактика и лечение / В.Ю. Мареев, И.В. Фомин, Ф.Т. Агеев [и
др.] // Кардиология. – 2018. – Т. 58 № s6. – С. 8–164.
100. Cohn, J.N. ACE inhibition and vascular remodeling of resistance vessels:
vascular compliance and cardiovascular implications // Heart disease. – 2000. – Vol. 2,
https://t.me/med1917
164
N 2. – P. 2–6.
101. Pathophysiology and Treatment of Diabetic Cardiomyopathy and Heart
Failure in Patients with Diabetes Mellitus. / K. Nakamura, T. Miyoshi, H. Ito [et al.] //
Int J Mol Sci. – 2022. – Vol. 23, N 7. – P. 1–14.
102. Grund, F. Three cardiac mysteries-stunning, hibernation and ischemic
preconditioning // Tidsskrift for den Norske laegeforening. – 2001. – Vol. 121, N 4.
– P. 440–444.
103. Kloner, R.A. Consequences of brief ischemia: stunning, preconditioning,
and their clinical implications / R.A. Kloner, R.B. Jennings. // Circulation. – 2001.
– Vol. 104, N 24. – P. 2981–2989.
104. Clinical relevance of hibernating myocardium in ischemic left ventricular
dysfunction / A.F. Schinkel, J.J. Bax, V. Delgado [et al.] // The American journal of
medicine. – 2010. – Vol. 123, N 11. – P. 978–986.
105. Predictors and long-term prognosis of left ventricular aneurysm in patients
with acute anterior myocardial infarction treated with primary percutaneous coronary
intervention in the contemporary era / J. You, L. Gao, Y. Shen [et al.] // Journal of
thoracic disease. – 2021. – Vol. 13, N 3. – P. 1706–1716.
106. Impact of glucose intolerance and insulin resistance on cardiac structure and
function: sex-related differences in the framingham heart study / M.K. Rutter, H. Parise,
E.J. Benjamin [et al.] // Circulation. – 2003. – Vol. 107, N 3. – P. 448–454.
107. Glycemic control and heart failure among adult patients with diabetes /
C. Iribarren, A.J. Karter, A.S. Go [et al.] // Circulation. – 2001. – Vol. 103, N 22.
– P. 2668–2673.
108. The incidence of congestive heart failure in type 2 diabetes: an update /
G.A. Nichols, C.M. Gullion, C.E. Koro [et al.] // Diabetes Care. – 2004. – Vol. 27, N 8.
https://t.me/med1917
165
– P. 1879–1884.
109. Relation of bundle branch block to long-term (four-year) mortality in
hospitalized patients with systolic heart failure / A. Barsheshet, I. Goldenberg, M. Garty
[et al.] // The American journal of cardiology. – 2011. – Vol. 107, N 4. – P. 540–544.
110. Arrhythmias and electrocardiographic changes in systolic heart failure
/ A. Devkota, A. Bakhit, A. Dufresne1 [et al.] // North American journal of medical
sciences. – 2016. – Vol. 8, N 4. – P. 171–174.
111. Higher hemoglobin A1c levels are associated with impaired left ventricular
diastolic function and higher incidence of adverse cardiac events in patients with
nonischemic dilated cardiomyopathy / Y. Ikeda, T. Inomata, T. Fujita [et al.] // Heart
and vessels. – 2017. – Vol. 32, N 4. – P. 446–457.
112. Association between diabetes and 1-year adverse clinical outcomes in a
multinational cohort of ambulatory patients with chronic heart failure: results from the
ESC-HFA heart failure long-term registry / M. Dauriz, G. Targher, C. Laroche [et al.] //
Diabetes Care. – 2017. – Vol. 40, N 5. – P. 671–678.
113. Regulation of protein kinase C by short term hyperglycaemia in human
platelets in vivo and in vitro / R. Assert, G. Scherk, A. Bumbure [et al.] // Diabetologia.
– 2001. – Vol. 44, N 2. – P. 188–195.
114. 2016 ESC Guidelines for the diagnosis and treatment of acute and chronic
heart failure: The Task Force for the diagnosis and treatment of acute and chronic heart
failure of the European Society of Cardiology (ESC). Developed with the special
contribution of the Heart Failure Association (HFA) of the ESC / P. Ponikowski, A.
Voors, S. Anker, [et al.] // Eur J Heart Fail. – 2016. – Vol. 18, N 8. – P. 891–975.
115. Role of Diabetes Mellitus in Acute Coronary Syndrome Patients with Heart
Failure and Midrange Ejection Fraction Who Have Undergone Percutaneous Coronary
https://t.me/med1917
166
Intervention: A 3-Year Case-Series Follow-Up Retrospective Study/ L. Li, G. Li, F. Lin
[et al.] // Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy. – 2021.
–Vol. 14. – P. 4931–4944.
116. Прогнозирование риска неблагоприятных сердечно-сосудистых
событий в отдаленном периоде после эпизода острого коронарного синдрома на
фоне сахарного диабета 2 типа / Е.А. Никитина, И.С. Мелетев, Е.Н. Чичерина [и
др.] // Кардиоваскулярная терапия и профилактика. – 2020. – Т. 19, № 3. –
С. 161–167.
117. Ramasamy, I. Biochemical markers in acute coronary syndrome // Clinica
chimica acta. – 2011. – Vol. 412, N 15/16. – P. 1279–1296.
118. Increased plasma levels of intermedin and brain natriuretic peptide
associated with severity of coronary stenosis in acute coronary syndrome / Y.-W. Qin,
X. Teng, J.-Q. He [et al.] // Peptides. – 2013. – N 42. – P. 84–88.
119. Heart Failure Association of the European Society of Cardiology. Heart
Failure Association of the European Society of Cardiology practical guidance on the use
of natriuretic peptide concentrations / C. Mueller, K.M. Donald, J.L. Januzzi. [et al.] //
Eur J Heart Fail. – 2019. – Vol. 21, N 6. – P. 715–731.
120. Obesity and natriuretic peptides, BNP and NT-proBNP: mechanisms and
diagnostic implications for heart failure / Ch. Madamanchi, H. Alhosaini, A. Sumida,
M.S. Runge. // International journal of cardiology. – 2014. – Vol. 176, N 3. –
P. 611–617.
121. The prognostic value of B-type natriuretic peptide in patients with acute
coronary syndromes / J.D. de Lemos, D.A. Morrow, J.H. Bentley [et al.] // The new
England journal of medicine. – 2001. – Vol. 345, N 14. – P. 1014–1021.
https://t.me/med1917
167
122. Omland, T. Advances in congestive heart failure management in the
intensive care unit: B-type natriuretic peptides in evaluation of acute heart failure //
Critical care medicine. – 2008. – N 36, Suppl 1. – P. 17–27.
123. Omland, T. New features of troponin testing in different clinical settings //
Journal of internal medicine. – 2010. – Vol. 268, N 3. – P. 207–217.
124. Glucose-insulin-potassium therapy in patients with ST-segment elevation
myocardial infarction / R. Diaz, A. Goyal, S.R. Mehta [et al.] // JAMA. – 2007.
– Vol. 298, N 20. – P. 2399–2405.
125. Glucometrics in patients hospitalized with acute myocardial infarction:
defining the optimal outcomes-based measure of risk / M. Kosiborod, S.E. Inzucchi,
H.M. Krumholz [et al.] // Circulation. – 2008. – Vol. 117, N 8. – P. 1018–1027.
126. Plasma N-terminal pro-brain natriuretic peptide and adrenomedullin: new
neurohormonal predictors of left ventricular function and prognosis after myocardial
infarction / A.M. Richards, M.G. Nicholls, T.G. Yandle [et al.] // Circulation. – 1998.
– Vol. 97, N 19. – P. 1921–1929.
127. Острый коронарный синдром без подъема сегмента ST
электрокардиограммы. Клинические рекомендации 2020 / О.Л. Барбараш, Д.В.
Дупляков, С.С. Якушин [и др.] // Российский кардиологический журнал. – 2021. –
Т. 26, № 4. – С. 149–202.
128. Determination of Angiographic (TIMI Grade) Blood Flow by Intracoronary
Doppler Flow Velocity During Acute Myocardial Infarction / M.J. Kern, J.A. Moore, T.
Wolford [et al.] // Circulation. – 1996. – Vol. 94, N 7. – P. 1545–1552.
129. Клинические рекомендации. Сахарный диабет 2 типа у взрослых / И.И.
Дедов, М.В. Шестакова, А.Ю. Майоров [и др.] // Сахарный диабет. – 2020. – Т. 23,
№ 2S. – С. 4–102.
https://t.me/med1917
168
130. Fractional flow reserve calculation from 3-dimensional quantitative coronary
angiography and TIMI frame count: a fast computer model to quantify the functional
significance of moderately obstructed coronary arteries / Sh. Tu, E. Barbato,
Z. Köszegi [et al.] // JACC. Cardiovascular interventions. – 2014. – Vol. 7,
N 7. – P. 768–777.
131. Sirolimus-eluting BiOSS LIM dedicated bifurcation stent in the treatment of
unprotected distal left main stenosis. / С. Briguori, G. Visconti, G. Signoriello [et al.]
// Catheter Cardiovasc Interv. – 2019. – T. 94, N 3. – P. 323–331.
132. Novel Insights of Jailed Balloon and Jailed Corsair Technique for
Percutaneous Coronary Intervention of Bifurcation Lesions / T. Kuno, T. Sugiyama, Y.
Numasawa [et al.] // Cardiovasc Revasc Med. – 2019. – Vol. 20, N 12. – P. 1065–1072.
133. 2019 ACC/AHA Guideline on the primary prevention of cardiovascular
disease: executive summary: a report of the American college of cardiology / American
heart association task forse on clinical practice guidelines / D.R. Arnett,
R.S. Blumenthal, M.A. Albert [et al.] // Journal of the American college of cardiology. –
2019. – Vol. 74, N 10. – P. 1376–1414.
134. Манченко, И.В. Сравнительная характеристика методов
интервенционного ведения больных со стенозом ствола левой коронарной
артерии или многососудистым поражением: коронарное шунтирование или
чрескожное коронарное вмешательство? (Обзор литературы) / И.В. Манченко,
Е.В. Седова, А.Г. Обрезан // Вестник Санкт-Петербургского университета.
Медицина. – 2010. – № 4. – С. 51–58.
135. Prognostic significance of mean platelet volume in diabetic patients with
ST-elevation myocardial infarction // A. Lekston, B. Hudzik, M. Hawranek [et al.] //
Journal of diabetes and its complications. – 2014. – Vol. 28, N 5. – P. 652–657.
https://t.me/med1917
169
136. Dual antiplatelet therapy in patients with diabetes and acute coronary
syndromes managed without revascularization / A.J. Dalby, S. Gottlieb, D.D. Cyr [et al.]
// American heart journal –2017. – Vol. 188. – P. 156–166.
137. Prognostic Importance of Physical Examination for Heart Failure in Non –
ST-Elevation Acute Coronary Syndromes: The Enduring Value of Killip Classification /
U.N. Khot, G. Jia, R.A. Harrington [et al] // JAMA. – 2003. – Vol. 290, N. 16. – P.
2174–2181.
138. Action to control cardiovascular risk in diabetes (ACCORD) trial: design
and methods / J.B. Buse, J.Th. Bigger, R.P. Byington [et al.] // The American journal of
cardiology. – 2007. – Vol. 99, N 12A. – P. 21i–33i.
139. 2018 ESC/EACTS Guidelines on myocardial revascularization /
F.-J. Neumann, M. Sousa-Uva, A. Ahlsson [et al.] // European heart journal. – 2019. –
Vol. 40, N 2. – P. 87–165.
140. Disparate impact of ischemic injury on regional wall dysfunction in acute
anterior vs inferior myocardial infarction / K.J. Feldmann, J.A. Goldstein, R. Gilbert [et
al.] // Cardiovascular revascularization medicine. – 2018. – Vol. 20, N 11. –
P. 965–972.
141. Pfeffer, M.A. Ventricular remodeling after myocardial infarction.
Experimental observations and clinical implications / M.A. Pfeffer, E. Braunwald //
Circulation. – 1990. – Vol.81. – P. 1161–1172.
142. Голухова, Е.З. Влияние сахарного диабета II типа на диастолическую
функцию миокарда левого желудочка у больных с ишемической болезнью сердца
/ Е.З. Голухова, А.З. Мустафаева // Креативная кардиология. – 2013. – № 2. –
С. 46–52.
https://t.me/med1917
170
143. Новиков, В.И. Количественная оценка эхокардиограммы.
Систолическая функция / В.И. Новиков, Т.И. Новикова // Эхокардиография.
Методика и количественная оценка / В.И. Новиков, Т.И. Новикова. – Москва :
МЕДпресс-информ, 2020. – С. 92–97.
144. Body surface area in normal-weight, overweight, and obese adults. A
comparison study / V. Johan, P.V. Heyning, W.D. Backer, L.V. Gaal // Metabolism –
Clinical and Experimental. – 2006. – Vol. 55, N 4. – P. 515–524.
145. Left ventricular unloading using an impella CP improves coronary flow and
infarct zone perfusion in ischemic heart failure / Sh. Watanabe, F. Kenneth, C.K. Jason
[et al.] // Journal of the American heart association. – 2018. – Vol. 7, N 6. – e1–11.
146. Ларина, В.Н. Краткий обзор обновлений клинических рекомендаций по
хронической сердечной недостаточности Европейского общества кардиологов
2021 года / В.Н. Ларина, И.К. Скиба, А.С. Скиба // Российский кардиологический
журнал. – 2022. – Т. 27, № 2. – С. 97–105.
147. Left ventricular remodeling after primary coronary angioplasty: patterns of
left ventricular dilation and long-term prognostic implications / L. Bolognese, A.N.
Neskovic, D. Antoniucci [et al.] // Circulation. – 2002. – Vol. 106, N 18. – P.
2351–2357.
148. Ремоделирование левого желудочка после острого инфаркта миокарда
и возможности его прогнозирования / Л.Л. Берштейн, В.И. Новиков, Ю.Н.
Гришкин [и др.] // Вестник Санкт-Петербургского университета. Медицина. –
2008. – Т. 11, № 2. – C. 3–17.
149. Left ventricular dyssynchrony acutely after myocardial infarction predicts
left ventricular remodeling / A.M. Sjoerd, S.L. Su, S.S. Matthew [et al.] // Journal of the
American College of Cardiology. – 2007. – Vol. 50, N 16. – P. 1532–1540.
https://t.me/med1917
Соседние файлы в папке Библиотека им академика М.И. Перельмана